Scarica l'app Stockscreener
1.15
0.01%
0.02
Precedente Chiudi:
$1.13
Aprire:
$1.13
Volume 24 ore:
61,100
Relative Volume:
0.36
Capitalizzazione di mercato:
$50.32M
Reddito:
$63.15M
Utile/perdita netta:
$-40.30M
Rapporto P/E:
-0.6886
EPS:
-1.67
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
+0.01%
1M Prestazione:
-3.41%
6M Prestazione:
-31.51%
1 anno Prestazione:
-60.35%
Intervallo 1D:
$1.10
$1.15
Intervallo di 1 settimana:
$1.09
$1.18
Portata 52W:
$0.8645
$3.0994
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Confronta TELA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.1301 | 50.32M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
126.00 | 218.14B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.06 | 141.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.81 | 135.84B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.71 | 126.45B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.69 | 49.71B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
Is TELA Bio Inc. stock a top pick in earnings seasonWeekly Market Outlook & Smart Swing Trading Techniques - Улправда
How sustainable is TELA Bio Inc. stock dividend payoutQuarterly Portfolio Summary & Growth Focused Entry Point Reports - Улправда
Is TELA Bio Inc. stock in correction or buying zone2025 Major Catalysts & Safe Capital Allocation Plans - Улправда
How TELA Bio Inc. stock reacts to bond yields2025 Bull vs Bear & Weekly Momentum Stock Picks - DonanımHaber
Will TELA Bio Inc. stock continue dividend increasesMarket Trend Summary & Real-Time Chart Breakout Alerts - Улправда
Whale Trades: Is TELA Bio Inc. stock a top pick in earnings seasonMarket Growth Review & Daily Stock Trend Watchlist - ulpravda.ru
Update Report: Is TELA Bio Inc. stock gaining market shareJuly 2025 Opening Moves & Safe Entry Momentum Tips - ulpravda.ru
Is TELA Bio Inc. stock gaining market shareTrade Volume Report & Risk Managed Investment Signals - Улправда
TELA Bio signals growth with new-hire equity grants - MSN
TELA Bio Signals Growth With New-Hire Equity Grants - MyChesCo
TELA Bio (TELA) price target decreased by 25.81% to 3.52 - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Associated Press | syndication news - Enidnews.com
What analysts say about TELA Bio Inc stockTrading Volume Surges & High Return Capital Growth - earlytimes.in
TELA Bio, Inc. (NASDAQ:TELA) Receives $3.25 Consensus Price Target from Analysts - Defense World
Resistance Check: Is TELA Bio Inc stock gaining market shareMarket Performance Summary & Entry Point Strategy Guides - BỘ NỘI VỤ
TELA Bio (TELA) Stock Analysis Report | Financials & Insights - Benzinga
TELA Bio stock price target lowered to $3 by Lake Street on sales issues - Investing.com South Africa
Lake Street Maintains TELA Bio (TELA) Buy Recommendation - Nasdaq
Lake Street Lowers Price Target for TELA Bio (TELA) Amid Continued Buy Rating | TELA Stock News - GuruFocus
TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference - MSN
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push - MSN
TELA Bio Inc Stock Analysis and ForecastPrice Gap Trading Strategies & Free Explosive Return Secrets - earlytimes.in
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
Goodwin Advises TELA Bio On $13 Million Underwritten Registered Direct Offering And Credit Refinancing - Mondaq
How to track smart money flows in TELA Bio Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
What MACD signals say about TELA Bio Inc.July 2025 Setups & Weekly High Return Forecasts - newser.com
Measuring TELA Bio Inc.’s beta against major indicesPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
How hedge fund analytics apply to TELA Bio Inc. stockBuy Signal & Expert Approved Trade Ideas - newser.com
How buybacks impact TELA Bio Inc. stock valuePortfolio Update Summary & Stepwise Swing Trade Plans - newser.com
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
TELA Bio (NASDAQ: TELA) to webcast Piper Sandler conference presentation on Dec. 3 - Stock Titan
TELA Bio (NASDAQ:TELA) Given New $4.00 Price Target at Canaccord Genuity Group - Defense World
Why TELA Bio Inc. stock is a value investor pickIPO Watch & Weekly Top Stock Performers List - newser.com
What dividend safety score for TELA Bio Inc. stockJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
Canaccord Genuity Lowers Price Target on TELA Bio (TELA) to $4.0 - GuruFocus
Major Investment Alert: EW Healthcare Partners Fund 2 Acquires Millions in TELA Bio Stock - TipRanks
Owner EW Healthcare Partners Fund 2 LP Buys 3,604,000 ($4M) Of Tela Bio Inc [TELA] - TradingView
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio (NASDAQ: TELA) grants 30,200 RSUs and 25,000 stock options as inducement awards - Stock Titan
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):